Search

Search Constraints

You searched for: Author/Creator Moses, Marcus

Search Results

1. Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer. (25th October 2021)

2. Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. (2020)

3. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Issue 7 (1st April 2021)

5. Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. (8th February 2021)

6. Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Issue 6 (12th December 2019)